In patients with hyperkalemia on maintenance hemodialysis, whether a combination of higher dialysate potassium with SZC can reduce the rates of AF and other clinically significant arrhythmias? Check out the VA by Madiha Aziz
EMPA KIDNEY long term follow-up - Visual Abstract
Ondansetron in Hemodialysis: The Visual Abstract
Is the use of Ondensetron safe in patients on hemodialysis? Checkout the VA by NSMC intern Santhoshi Bavi
The FINE-HEART Visual Abstract
Checkout the visual depiction of pooled analysis of the Fine-Heart study by NSMC Intern Kajaree Giri.
FELZARTAMAB in Antibody Mediated Rejection - The Visual Abstract
Can felzartamab represent a new hope for antibody-mediated rejection? Check out the visual abstract by Shahin Mohammed
The ESPRIT Trial Visual Abstract
Does strict BP control help prevent major vascular events in patients with high CV risk? Check out the VA by NSMC intern Francisco Santamaria
PROTECTION trial - visual abstract
Should We Protect Kidney Function with Intravenous Amino Acids? Checkout the colorful VA of PROTECTION Trial by NSMC Intern Samantha Verdugo .
Risk of hypertension post living kidney donation - The Visual Abstract
The RADAR study - Visual Abstract
Are patients with rare kidney diseases different from other CKD? Check out the beautiful VAs by NSMC faculty Brian Rifkin and Cristina Popa
COMPASS Trial post hoc analysis - The Visual Abstract
Are proton pump inhibitors detrimental to kidney function?
Checkout the visual abstract for the post hoc observational analysis from the COMPASS Trial by NSMC Intern Rowan Zyada!
FLOW- the Visual Abstract
‘FLOW’ing with the Semaglu’TIDE’!
Check the beautiful visual abstract made by NephEdC intern Anjana Gopal, with an appearance of the Gila monster as well.
KDIGO 2024 CKD guidelines part 2 - Visual Abstract
Checkout the top 10 takeaways by KDIGO on the management of people with CKD. VA by Dr Vamsidhar Veeranki
KDIGO CKD GUIDELINES - VISUAL ABSTRACT
Check out the TOP 10 takeaways from KDIGO - CKD guidelines on evaluation of people with or at risk of CKD by NSMC Intern Stephanie Torres
The NeflgArd Part B Visual Abstract
Does targeted-release formulation of Budesonide improve kidney function in primary IgA Nephropathy? Check out the VA by NSMC Intern Anant Pilawan on NefIgArd part B trial
PRAECIS - Visual Abstract
NSMC Intern Elba Medina creates a crisp VA for the PRAECIS trial.
Also, we have some bonus VAs this time created for NephMadness by our VA editor Divya Bajpai!
Global disparities in kidney disease burden and care - Visual Abstract
The SLEEP-HD Visual Abstract
Check out the dreamy Visual Abstract by Cristina Popa
Any sleep potion for insomnia in patients on hemodialysis?
ECULIZUMAB in STEC - HUS - a Visual Abstract
Is eculizumab effective in pediatric patients with Shiga toxin-related E. Coli hemolytic uremic syndrome?
Check out the visual abstract by Melvin Chan for the answer.
Aldosterone Synthase Inhibitors in Proteinuric CKD: the Visual Abstract
Yet another new medication class for use in the RAAS cascade. BI 690517, an aldosterone synthase inhibitor, has been shown to significantly reduce proteinuria with or without empagliflozin. VA by Brian Rifkin.
ZENITH: the visual abstract
A very colourful visual abstract from Sabarinath!